You May Also Like

Patient information : the 12-dose regimen for latent tuberculosis (TB) infection
Cite
CITE Title : Patient information : the 12-dose regimen for latent tuberculosis (TB) infection Corporate Authors(s) : National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.) Published Date : 6/28/18 URL : https://stacks.cdc.gov/view/cdc/56544 National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.) (2018). Patient information : the 12-dose regimen for latent tuberculosis (TB) infection. National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.) "Patient information : the 12-dose regimen for latent tuberculosis (TB) infection" (2018) National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.) "Patient information : the 12-dose regimen for latent tuberculosis (TB) infection" , 2018 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 150.71 KB]
Corporate Authors:
National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.)
6/28/18
Description:
To treat your latent TB infection, take two medicines (rifapentine and isoniazid) once a week, for 12 weeks. It is important to take all of your medic...
File Type:
[PDF - 150.71 KB]
File Type:
[PDF - 150.71 KB]

Medication tracker : the 12-dose regimen for latent tuberculosis (TB) infection
Cite
CITE Title : Medication tracker : the 12-dose regimen for latent tuberculosis (TB) infection Corporate Authors(s) : National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.) Published Date : 6/21/18 URL : https://stacks.cdc.gov/view/cdc/56545 National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.) (2018). Medication tracker : the 12-dose regimen for latent tuberculosis (TB) infection. National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.) "Medication tracker : the 12-dose regimen for latent tuberculosis (TB) infection" (2018) National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.) "Medication tracker : the 12-dose regimen for latent tuberculosis (TB) infection" , 2018 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 155.65 KB]
Corporate Authors:
National Center for HIV/AIDS, Viral Hepatis, STD, and TB Prevention (U.S.)
6/21/18
Description:
CS292653BPublication date from document properties.LTBI_Medication_Tracker.pdf
File Type:
[PDF - 155.65 KB]
File Type:
[PDF - 155.65 KB]